456 related articles for article (PubMed ID: 32795766)
1. Hydrogen sulfide donors: Therapeutic potential in anti-atherosclerosis.
Zhang H; Bai Z; Zhu L; Liang Y; Fan X; Li J; Wen H; Shi T; Zhao Q; Wang Z
Eur J Med Chem; 2020 Nov; 205():112665. PubMed ID: 32795766
[TBL] [Abstract][Full Text] [Related]
2. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.
Xu S; Liu Z; Liu P
Int J Cardiol; 2014 Mar; 172(2):313-7. PubMed ID: 24491853
[TBL] [Abstract][Full Text] [Related]
3. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis.
Mani S; Li H; Untereiner A; Wu L; Yang G; Austin RC; Dickhout JG; Lhoták Š; Meng QH; Wang R
Circulation; 2013 Jun; 127(25):2523-34. PubMed ID: 23704252
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential.
Lynn EG; Austin RC
Expert Rev Clin Pharmacol; 2011 Jan; 4(1):97-108. PubMed ID: 22115351
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage.
Wang XH; Wang F; You SJ; Cao YJ; Cao LD; Han Q; Liu CF; Hu LF
Cell Signal; 2013 Nov; 25(11):2255-62. PubMed ID: 23872072
[TBL] [Abstract][Full Text] [Related]
6. Atherosclerosis and the Hydrogen Sulfide Signaling Pathway - Therapeutic Approaches to Disease Prevention.
Wang ZJ; Wu J; Guo W; Zhu YZ
Cell Physiol Biochem; 2017; 42(3):859-875. PubMed ID: 28641276
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation.
Lin Y; Chen Y; Zhu N; Zhao S; Fan J; Liu E
Biomed Pharmacother; 2016 Oct; 83():466-476. PubMed ID: 27427853
[TBL] [Abstract][Full Text] [Related]
8. Sulfhydrated Sirtuin-1 Increasing Its Deacetylation Activity Is an Essential Epigenetics Mechanism of Anti-Atherogenesis by Hydrogen Sulfide.
Du C; Lin X; Xu W; Zheng F; Cai J; Yang J; Cui Q; Tang C; Cai J; Xu G; Geng B
Antioxid Redox Signal; 2019 Jan; 30(2):184-197. PubMed ID: 29343087
[No Abstract] [Full Text] [Related]
9. Hydrogen sulfide and the pathogenesis of atherosclerosis.
Mani S; Untereiner A; Wu L; Wang R
Antioxid Redox Signal; 2014 Feb; 20(5):805-17. PubMed ID: 23582095
[TBL] [Abstract][Full Text] [Related]
10. Anti-atherogenic effect of hydrogen sulfide by over-expression of cystathionine gamma-lyase (CSE) gene.
Cheung SH; Kwok WK; To KF; Lau JY
PLoS One; 2014; 9(11):e113038. PubMed ID: 25397776
[TBL] [Abstract][Full Text] [Related]
11. International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H
Szabo C; Papapetropoulos A
Pharmacol Rev; 2017 Oct; 69(4):497-564. PubMed ID: 28978633
[TBL] [Abstract][Full Text] [Related]
12. H
Monti M; Terzuoli E; Ziche M; Morbidelli L
Pharmacol Res; 2016 Nov; 113(Pt A):426-437. PubMed ID: 27650753
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide in pharmacology and medicine--An update.
Bełtowski J
Pharmacol Rep; 2015 Jun; 67(3):647-58. PubMed ID: 25933982
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide and endothelial dysfunction: relationship with nitric oxide.
Altaany Z; Moccia F; Munaron L; Mancardi D; Wang R
Curr Med Chem; 2014; 21(32):3646-61. PubMed ID: 25005182
[TBL] [Abstract][Full Text] [Related]
15. H
Magli E; Perissutti E; Santagada V; Caliendo G; Corvino A; Esposito G; Esposito G; Fiorino F; Migliaccio M; Scognamiglio A; Severino B; Sparaco R; Frecentese F
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944543
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen sulfide and its donors: Novel antitumor and antimetastatic agents for liver cancer.
Zhang CH; Jiang ZL; Meng Y; Yang WY; Zhang XY; Zhang YX; Khattak S; Ji XY; Wu DD
Cell Signal; 2023 Jun; 106():110628. PubMed ID: 36774973
[TBL] [Abstract][Full Text] [Related]
17. Anti-atherosclerosis effect of H
Bai Z; Zhang J; Zhang Q; Wang Y; Li J; Zhao Q; Wang Z; He D; Zhang J; Liu B
Bioorg Med Chem; 2019 Aug; 27(15):3307-3318. PubMed ID: 31204228
[TBL] [Abstract][Full Text] [Related]
18. Effects of gut microbiota on atherosclerosis through hydrogen sulfide.
Gui DD; Luo W; Yan BJ; Ren Z; Tang ZH; Liu LS; Zhang JF; Jiang ZS
Eur J Pharmacol; 2021 Apr; 896():173916. PubMed ID: 33529724
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen sulfide metabolism regulates endothelial solute barrier function.
Yuan S; Pardue S; Shen X; Alexander JS; Orr AW; Kevil CG
Redox Biol; 2016 Oct; 9():157-166. PubMed ID: 27552214
[TBL] [Abstract][Full Text] [Related]
20. Development and Application of Carbonyl Sulfide-Based Donors for H
Levinn CM; Cerda MM; Pluth MD
Acc Chem Res; 2019 Sep; 52(9):2723-2731. PubMed ID: 31390174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
